Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph II/III Veliparib Or Placebo In Combo W/ Adjuv Temozolomide In GBM W/ Mgmt Promoter Hypermethylati

Protocol: ALLIANCE-A071102

Full Title

A Phase II/III Randomized Trial of Veliparib or Placebo in Combination with Adjuvant Temozolomide in Newly Diagnosed Glioblastoma with MGMT Promoter Hypermethylation